Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India Pharma Fund · Regular ✕HDFC Pharma and Healthcare Fund · Regular ✕

Growth of ₹10,000

Basics

Nippon India Pharma FundHDFC Pharma and Healthcare Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseNippon IndiaHDFC
NAV₹591.2429₹22.8170
NAV date20 Nov 202620 Nov 2026
History20.6 years3.1 years
Expense ratio1.8%2.1%
Stars★★★★★★★★★★
Growth Score78.1093.90

Returns

Nippon India Pharma FundHDFC Pharma and Healthcare Fund
1 month+11.32%+12.87%
3 months+3.52%+6.85%
6 months+8.09%+17.20%
YTD+16.05%+32.43%
1 year+14.27%+30.73%
3 years (CAGR)+16.91%+29.16%
5 years (CAGR)+14.37%—
10 years (CAGR)+15.58%—
Since launch+17.64%+30.28%

Risk

Nippon India Pharma FundHDFC Pharma and Healthcare Fund
Volatility14.1%15.8%
Downside volatility9.1%8.6%
Sharpe0.741.44
Sortino1.152.64
Calmar1.141.94
Return / risk1.201.85
Deepest fall−47.36%−15.07%
Days to recover301133
Below its high+0.00%+0.00%

Against benchmark

Nippon India Pharma FundHDFC Pharma and Healthcare Fund
Alpha−2.75%+6.36%
Beta0.890.97
R²89.5%85.0%
Up capture83.5%106.7%
Down capture91.2%74.4%
Tracking error4.8%6.1%
Information ratio−0.880.97
Treynor0.110.22

Consistency

Nippon India Pharma FundHDFC Pharma and Healthcare Fund
Best 1-year+175.79%+64.96%
Middle 1-year+13.84%+21.84%
Worst 1-year−36.67%+0.52%
1-year periods with a loss23.4%0.0%
Middle 3-year+20.93%+28.68%
Positive months63.9%69.4%
Best day+3.40%+3.19%
Worst day−3.21%−3.62%
Worst 5% day−1.38%−1.50%
Positive days53.7%58.1%
NAVs a year247247

SIP of ₹10,000 a month

Nippon India Pharma FundHDFC Pharma and Healthcare Fund
5-year XIRR+17.18%—
5-year value₹9,29,284—
3-year XIRR+13.26%+26.26%
1-year XIRR+21.05%+39.84%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth